10 20 30 40 50 60 70 80 1PGG - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER OXIDOREDUCTASE 02-DEC-95 1PGG
TITLE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH 1-(4-IODOBENZOYL)-5- TITLE 2 METHOXY-2-METHYLINDOLE-3-ACETIC ACID (IODOINDOMETHACIN), TRANS MODEL
COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROSTAGLANDIN H2 SYNTHASE-1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CYCLOOXYGENASE I; COMPND 5 EC: 1.14.99.1
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: OVIS ARIES; SOURCE 3 ORGANISM_COMMON: SHEEP; SOURCE 4 ORGANISM_TAXID: 9940; SOURCE 5 ORGANELLE: SEMINAL VESICLE
KEYWDS OXIDOREDUCTASE, DIOXYGENASE, PEROXIDASE
EXPDTA X-RAY DIFFRACTION
AUTHOR P.J.LOLL,D.PICOT,R.M.GARAVITO
REVDAT 3 13-JUL-11 1PGG 1 VERSN REVDAT 2 24-FEB-09 1PGG 1 VERSN REVDAT 1 11-JAN-97 1PGG 0
JRNL AUTH P.J.LOLL,D.PICOT,O.EKABO,R.M.GARAVITO JRNL TITL SYNTHESIS AND USE OF IODINATED NONSTEROIDAL ANTIINFLAMMATORY JRNL TITL 2 DRUG ANALOGS AS CRYSTALLOGRAPHIC PROBES OF THE PROSTAGLANDIN JRNL TITL 3 H2 SYNTHASE CYCLOOXYGENASE ACTIVE SITE. JRNL REF BIOCHEMISTRY V. 35 7330 1996 JRNL REFN ISSN 0006-2960 JRNL PMID 8652509 JRNL DOI 10.1021/BI952776W
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.J.LOLL,D.PICOT,R.M.GARAVITO REMARK 1 TITL THE STRUCTURAL BASIS OF ASPIRIN ACTIVITY INFERRED FROM THE REMARK 1 TITL 2 CRYSTAL STRUCTURE OF INACTIVATED PROSTAGLANDIN H2 SYNTHASE REMARK 1 REF NAT.STRUCT.BIOL. V. 2 637 1995 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.PICOT,P.J.LOLL,R.M.GARAVITO REMARK 1 TITL THE X-RAY CRYSTAL STRUCTURE OF THE MEMBRANE PROTEIN REMARK 1 TITL 2 PROSTAGLANDIN H2 SYNTHASE-1 REMARK 1 REF NATURE V. 367 243 1994 REMARK 1 REFN ISSN 0028-0836
REMARK 2 REMARK 2 RESOLUTION. 4.50 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 4.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 79.2 REMARK 3 NUMBER OF REFLECTIONS : 8235 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.254 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 945 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8954 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 248 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.015 REMARK 3 BOND ANGLES (DEGREES) : 1.99 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.73 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE STARTING MODEL FOR THIS REFINEMENT WAS THE 3.1 REMARK 3 ANGSTROM REFINED CRYSTAL STRUCTURE OF THE PROSTAGLANDIN REMARK 3 SYNTHASE-FLURBIPROFEN COMPLEX, FOR WHICH INDIVIDUAL REMARK 3 ISOTROPIC ATOMIC TEMPERATURE FACTORS WERE REFINED. THESE REMARK 3 B-VALUES WERE USED FOR THIS STRUCTURE WITHOUT FURTHER REMARK 3 REFINEMENT. REMARK 3 REMARK 3 THE LOW RESOLUTION OF THE IODOINDOMETHACIN COMPLEX REMARK 3 STRUCTURE PRECLUDED REFINEMENT OF ALL ATOMIC POSITIONS. REMARK 3 RATHER, THE TWO HALVES OF THE DIMER WERE SUBJECTED TO REMARK 3 RIGID BODY REFINEMENT, SUBJECT TO NON-CRYSTALLOGRAPHIC REMARK 3 SYMMETRY CONSTRAINTS. THE DRUG WAS THEN PLACED IN THE REMARK 3 ACTIVE SITE, WHERE CLEAR ELECTRON DENSITY WAS SEEN FOR REMARK 3 FOR THE IODINE ATOM ONLY. THE REMAINDER OF THE DRUG WAS REMARK 3 CONSTRUCTED BY MODEL-BUILDING AND ITS POSITION REFINED REMARK 3 BY RIGID BODY METHODS. THE EXPERIMENTAL ELECTRON DENSITY REMARK 3 DOES NOT ALLOW FOR UNAMBIGUOUS POSITIONING OF THE LIGHT REMARK 3 ATOMS OF THE INHIBITOR. AFTER RIGID BODY MINIMIZATION, REMARK 3 THE STRUCTURE WAS FURTHER REFINED BY ALLOWING ONLY THOSE REMARK 3 ATOMS WITHIN AN 8 ANGSTROM SPHERE CENTERED ON ON THE REMARK 3 INHIBITOR TO MOVE. TWO POSSIBLE CONFORMATIONS OF THE REMARK 3 DRUG WERE FOUND, BOTH OF WHICH WERE CONSISTENT WITH THE REMARK 3 OBSERVED HEAVY ATOM DENSITY; THESE CORRESPOND TO THE CIS REMARK 3 AND TRANS ROTATIONAL CONFORMERS OF THE DRUG. THIS FILE REMARK 3 SHOWS THE RESULTS OF THE REFINEMENT OF THE TRANS MODEL.
REMARK 4 REMARK 4 1PGG COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : DEC-94 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : AREA DETECTOR REMARK 200 DETECTOR MANUFACTURER : ENRAF-NONIUS FAST REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MADNES REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11169 REMARK 200 RESOLUTION RANGE HIGH (A) : 4.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 79.7 REMARK 200 DATA REDUNDANCY : 1.700 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.1 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 72.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 49.61000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 104.49500 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 116.21500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 49.61000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 104.49500 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 116.21500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 49.61000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 104.49500 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 116.21500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 49.61000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 104.49500 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 116.21500 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 40900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -38.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 25 REMARK 465 ASP A 26 REMARK 465 PRO A 27 REMARK 465 GLY A 28 REMARK 465 ALA A 29 REMARK 465 PRO A 30 REMARK 465 ALA A 31 REMARK 465 PRO A 32 REMARK 465 ASP A 584 REMARK 465 PRO A 585 REMARK 465 ARG A 586 REMARK 465 GLN A 587 REMARK 465 GLU A 588 REMARK 465 ASP A 589 REMARK 465 ARG A 590 REMARK 465 PRO A 591 REMARK 465 GLY A 592 REMARK 465 VAL A 593 REMARK 465 GLU A 594 REMARK 465 ARG A 595 REMARK 465 PRO A 596 REMARK 465 PRO A 597 REMARK 465 THR A 598 REMARK 465 GLU A 599 REMARK 465 LEU A 600 REMARK 465 ALA B 25 REMARK 465 ASP B 26 REMARK 465 PRO B 27 REMARK 465 GLY B 28 REMARK 465 ALA B 29 REMARK 465 PRO B 30 REMARK 465 ALA B 31 REMARK 465 PRO B 32 REMARK 465 ASP B 584 REMARK 465 PRO B 585 REMARK 465 ARG B 586 REMARK 465 GLN B 587 REMARK 465 GLU B 588 REMARK 465 ASP B 589 REMARK 465 ARG B 590 REMARK 465 PRO B 591 REMARK 465 GLY B 592 REMARK 465 VAL B 593 REMARK 465 GLU B 594 REMARK 465 ARG B 595 REMARK 465 PRO B 596 REMARK 465 PRO B 597 REMARK 465 THR B 598 REMARK 465 GLU B 599 REMARK 465 LEU B 600
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 86 C - N - CA ANGL. DEV. = 10.2 DEGREES REMARK 500 LEU A 408 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 ARG A 433 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 PRO B 86 C - N - CA ANGL. DEV. = 10.1 DEGREES REMARK 500 LEU B 408 N - CA - C ANGL. DEV. = 17.0 DEGREES REMARK 500 ARG B 433 NE - CZ - NH1 ANGL. DEV. = 3.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 129 -84.19 -112.65 REMARK 500 ASP A 135 43.66 -95.81 REMARK 500 PRO A 156 134.95 -39.52 REMARK 500 LYS A 211 69.50 -160.76 REMARK 500 ASP A 249 13.50 57.98 REMARK 500 TYR A 254 -178.62 178.52 REMARK 500 PRO A 270 74.91 -57.63 REMARK 500 LEU A 294 46.32 -103.05 REMARK 500 LEU A 295 112.74 168.62 REMARK 500 GLN A 358 94.49 -66.03 REMARK 500 LEU A 384 -15.54 -48.77 REMARK 500 LEU A 408 -51.89 -29.40 REMARK 500 ASN A 410 88.87 -67.91 REMARK 500 LEU A 481 -71.11 -69.88 REMARK 500 PHE A 503 -76.02 -52.16 REMARK 500 PRO A 514 -90.35 2.20 REMARK 500 GLU A 520 -76.64 -24.48 REMARK 500 PRO A 528 -78.29 -48.30 REMARK 500 LEU A 534 -60.91 -92.14 REMARK 500 ALA A 562 150.27 -47.01 REMARK 500 THR B 129 -84.17 -112.66 REMARK 500 ASP B 135 43.72 -95.83 REMARK 500 PRO B 156 134.97 -39.57 REMARK 500 LYS B 211 69.53 -160.80 REMARK 500 ASP B 249 13.53 57.99 REMARK 500 TYR B 254 -178.59 178.54 REMARK 500 PRO B 270 74.92 -57.65 REMARK 500 LEU B 294 46.37 -103.10 REMARK 500 LEU B 295 112.71 168.61 REMARK 500 GLN B 358 94.53 -66.04 REMARK 500 LEU B 384 -15.51 -48.84 REMARK 500 LEU B 408 -51.83 -29.48 REMARK 500 ASN B 410 88.83 -67.93 REMARK 500 LEU B 481 -71.11 -69.89 REMARK 500 PHE B 503 -76.00 -52.17 REMARK 500 PRO B 514 -90.33 2.15 REMARK 500 GLU B 520 -76.60 -24.52 REMARK 500 PRO B 528 -78.29 -48.34 REMARK 500 LEU B 534 -60.87 -92.12 REMARK 500 ALA B 562 150.26 -46.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 TYR A 39 0.07 SIDE CHAIN REMARK 500 TYR B 39 0.07 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 VAL A 287 24.2 L L OUTSIDE RANGE REMARK 500 LEU A 408 17.7 L L OUTSIDE RANGE REMARK 500 VAL B 287 24.2 L L OUTSIDE RANGE REMARK 500 LEU B 408 17.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 388 NE2 REMARK 620 2 HEM A 601 NA 79.7 REMARK 620 3 HEM A 601 NB 84.8 95.6 REMARK 620 4 HEM A 601 NC 94.2 170.3 91.4 REMARK 620 5 HEM A 601 ND 86.5 83.5 171.4 88.5 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 388 NE2 REMARK 620 2 HEM B 601 NA 79.7 REMARK 620 3 HEM B 601 NB 84.8 95.5 REMARK 620 4 HEM B 601 NC 94.2 170.3 91.4 REMARK 620 5 HEM B 601 ND 86.6 83.6 171.4 88.6 REMARK 620 N 1 2 3 4
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: COX REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE CYCLOOXYGENASE ACTIVE SITE IS LOCATED WITHIN REMARK 800 A LONG HYDROPHOBIC CHANNEL AT A REGION DEFINED BY RESIDUES ARG REMARK 800 120, SER 530 (SITE OF ASPIRIN ACETYLATION), TYR 385, AND GLU 524. REMARK 800 (A CHAIN) REMARK 800 REMARK 800 SITE_IDENTIFIER: PER REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE PEROXIDASE ACTIVE SITE IS AT THE HEME (HEM REMARK 800 601) SITE. HIS 388 IS THE PROXIMAL HEME LIGAND. (A CHAIN) REMARK 800 REMARK 800 SITE_IDENTIFIER: COB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE CYCLOOXYGENASE ACTIVE SITE IS LOCATED WITHIN REMARK 800 A LONG HYDROPHOBIC CHANNEL AT A REGION DEFINED BY RESIDUES ARG REMARK 800 120, SER 530 (SITE OF ASPIRIN ACETYLATION), TYR 385, AND GLU 524. REMARK 800 (B CHAIN) REMARK 800 REMARK 800 SITE_IDENTIFIER: PEB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE PEROXIDASE ACTIVE SITE IS AT THE HEME (HEM REMARK 800 601) SITE. HIS 388 IS THE PROXIMAL HEME LIGAND. (B CHAIN) REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 661 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 671 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 672 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG A 681 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 661 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 671 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 672 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NAG B 681 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMM A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IMM B 1
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS SEQUENCE IS FOUND IN ENTRY 1PRH. THE NUMBERING IS REMARK 999 DERIVED FROM THE PRE-PROTEIN, WHICH CONTAINS A 24-RESIDUE REMARK 999 SIGNAL SEQUENCE WHICH IS CLEAVED DURING MATURATION. REMARK 999 NOTE THAT THE FOLLOWING SEQUENCE CORRESPONDS ONLY TO THE REMARK 999 RESIDUES SEEN IN THE EXPERIMENTAL ELECTRON DENSITY MAP, REMARK 999 AND COMMENCES AT RESIDUE 33
DBREF 1PGG A 25 600 PIR A29947 A29947 24 599 DBREF 1PGG B 25 600 PIR A29947 A29947 24 599
SEQRES 1 A 576 ALA ASP PRO GLY ALA PRO ALA PRO VAL ASN PRO CYS CYS SEQRES 2 A 576 TYR TYR PRO CYS GLN HIS GLN GLY ILE CYS VAL ARG PHE SEQRES 3 A 576 GLY LEU ASP ARG TYR GLN CYS ASP CYS THR ARG THR GLY SEQRES 4 A 576 TYR SER GLY PRO ASN CYS THR ILE PRO GLU ILE TRP THR SEQRES 5 A 576 TRP LEU ARG THR THR LEU ARG PRO SER PRO SER PHE ILE SEQRES 6 A 576 HIS PHE LEU LEU THR HIS GLY ARG TRP LEU TRP ASP PHE SEQRES 7 A 576 VAL ASN ALA THR PHE ILE ARG ASP THR LEU MET ARG LEU SEQRES 8 A 576 VAL LEU THR VAL ARG SER ASN LEU ILE PRO SER PRO PRO SEQRES 9 A 576 THR TYR ASN ILE ALA HIS ASP TYR ILE SER TRP GLU SER SEQRES 10 A 576 PHE SER ASN VAL SER TYR TYR THR ARG ILE LEU PRO SER SEQRES 11 A 576 VAL PRO ARG ASP CYS PRO THR PRO MET GLY THR LYS GLY SEQRES 12 A 576 LYS LYS GLN LEU PRO ASP ALA GLU PHE LEU SER ARG ARG SEQRES 13 A 576 PHE LEU LEU ARG ARG LYS PHE ILE PRO ASP PRO GLN GLY SEQRES 14 A 576 THR ASN LEU MET PHE ALA PHE PHE ALA GLN HIS PHE THR SEQRES 15 A 576 HIS GLN PHE PHE LYS THR SER GLY LYS MET GLY PRO GLY SEQRES 16 A 576 PHE THR LYS ALA LEU GLY HIS GLY VAL ASP LEU GLY HIS SEQRES 17 A 576 ILE TYR GLY ASP ASN LEU GLU ARG GLN TYR GLN LEU ARG SEQRES 18 A 576 LEU PHE LYS ASP GLY LYS LEU LYS TYR GLN MET LEU ASN SEQRES 19 A 576 GLY GLU VAL TYR PRO PRO SER VAL GLU GLU ALA PRO VAL SEQRES 20 A 576 LEU MET HIS TYR PRO ARG GLY ILE PRO PRO GLN SER GLN SEQRES 21 A 576 MET ALA VAL GLY GLN GLU VAL PHE GLY LEU LEU PRO GLY SEQRES 22 A 576 LEU MET LEU TYR ALA THR ILE TRP LEU ARG GLU HIS ASN SEQRES 23 A 576 ARG VAL CYS ASP LEU LEU LYS ALA GLU HIS PRO THR TRP SEQRES 24 A 576 GLY ASP GLU GLN LEU PHE GLN THR ALA ARG LEU ILE LEU SEQRES 25 A 576 ILE GLY GLU THR ILE LYS ILE VAL ILE GLU GLU TYR VAL SEQRES 26 A 576 GLN GLN LEU SER GLY TYR PHE LEU GLN LEU LYS PHE ASP SEQRES 27 A 576 PRO GLU LEU LEU PHE GLY ALA GLN PHE GLN TYR ARG ASN SEQRES 28 A 576 ARG ILE ALA MET GLU PHE ASN GLN LEU TYR HIS TRP HIS SEQRES 29 A 576 PRO LEU MET PRO ASP SER PHE ARG VAL GLY PRO GLN ASP SEQRES 30 A 576 TYR SER TYR GLU GLN PHE LEU PHE ASN THR SER MET LEU SEQRES 31 A 576 VAL ASP TYR GLY VAL GLU ALA LEU VAL ASP ALA PHE SER SEQRES 32 A 576 ARG GLN PRO ALA GLY ARG ILE GLY GLY GLY ARG ASN ILE SEQRES 33 A 576 ASP HIS HIS ILE LEU HIS VAL ALA VAL ASP VAL ILE LYS SEQRES 34 A 576 GLU SER ARG VAL LEU ARG LEU GLN PRO PHE ASN GLU TYR SEQRES 35 A 576 ARG LYS ARG PHE GLY MET LYS PRO TYR THR SER PHE GLN SEQRES 36 A 576 GLU LEU THR GLY GLU LYS GLU MET ALA ALA GLU LEU GLU SEQRES 37 A 576 GLU LEU TYR GLY ASP ILE ASP ALA LEU GLU PHE TYR PRO SEQRES 38 A 576 GLY LEU LEU LEU GLU LYS CYS HIS PRO ASN SER ILE PHE SEQRES 39 A 576 GLY GLU SER MET ILE GLU MET GLY ALA PRO PHE SER LEU SEQRES 40 A 576 LYS GLY LEU LEU GLY ASN PRO ILE CYS SER PRO GLU TYR SEQRES 41 A 576 TRP LYS ALA SER THR PHE GLY GLY GLU VAL GLY PHE ASN SEQRES 42 A 576 LEU VAL LYS THR ALA THR LEU LYS LYS LEU VAL CYS LEU SEQRES 43 A 576 ASN THR LYS THR CYS PRO TYR VAL SER PHE HIS VAL PRO SEQRES 44 A 576 ASP PRO ARG GLN GLU ASP ARG PRO GLY VAL GLU ARG PRO SEQRES 45 A 576 PRO THR GLU LEU SEQRES 1 B 576 ALA ASP PRO GLY ALA PRO ALA PRO VAL ASN PRO CYS CYS SEQRES 2 B 576 TYR TYR PRO CYS GLN HIS GLN GLY ILE CYS VAL ARG PHE SEQRES 3 B 576 GLY LEU ASP ARG TYR GLN CYS ASP CYS THR ARG THR GLY SEQRES 4 B 576 TYR SER GLY PRO ASN CYS THR ILE PRO GLU ILE TRP THR SEQRES 5 B 576 TRP LEU ARG THR THR LEU ARG PRO SER PRO SER PHE ILE SEQRES 6 B 576 HIS PHE LEU LEU THR HIS GLY ARG TRP LEU TRP ASP PHE SEQRES 7 B 576 VAL ASN ALA THR PHE ILE ARG ASP THR LEU MET ARG LEU SEQRES 8 B 576 VAL LEU THR VAL ARG SER ASN LEU ILE PRO SER PRO PRO SEQRES 9 B 576 THR TYR ASN ILE ALA HIS ASP TYR ILE SER TRP GLU SER SEQRES 10 B 576 PHE SER ASN VAL SER TYR TYR THR ARG ILE LEU PRO SER SEQRES 11 B 576 VAL PRO ARG ASP CYS PRO THR PRO MET GLY THR LYS GLY SEQRES 12 B 576 LYS LYS GLN LEU PRO ASP ALA GLU PHE LEU SER ARG ARG SEQRES 13 B 576 PHE LEU LEU ARG ARG LYS PHE ILE PRO ASP PRO GLN GLY SEQRES 14 B 576 THR ASN LEU MET PHE ALA PHE PHE ALA GLN HIS PHE THR SEQRES 15 B 576 HIS GLN PHE PHE LYS THR SER GLY LYS MET GLY PRO GLY SEQRES 16 B 576 PHE THR LYS ALA LEU GLY HIS GLY VAL ASP LEU GLY HIS SEQRES 17 B 576 ILE TYR GLY ASP ASN LEU GLU ARG GLN TYR GLN LEU ARG SEQRES 18 B 576 LEU PHE LYS ASP GLY LYS LEU LYS TYR GLN MET LEU ASN SEQRES 19 B 576 GLY GLU VAL TYR PRO PRO SER VAL GLU GLU ALA PRO VAL SEQRES 20 B 576 LEU MET HIS TYR PRO ARG GLY ILE PRO PRO GLN SER GLN SEQRES 21 B 576 MET ALA VAL GLY GLN GLU VAL PHE GLY LEU LEU PRO GLY SEQRES 22 B 576 LEU MET LEU TYR ALA THR ILE TRP LEU ARG GLU HIS ASN SEQRES 23 B 576 ARG VAL CYS ASP LEU LEU LYS ALA GLU HIS PRO THR TRP SEQRES 24 B 576 GLY ASP GLU GLN LEU PHE GLN THR ALA ARG LEU ILE LEU SEQRES 25 B 576 ILE GLY GLU THR ILE LYS ILE VAL ILE GLU GLU TYR VAL SEQRES 26 B 576 GLN GLN LEU SER GLY TYR PHE LEU GLN LEU LYS PHE ASP SEQRES 27 B 576 PRO GLU LEU LEU PHE GLY ALA GLN PHE GLN TYR ARG ASN SEQRES 28 B 576 ARG ILE ALA MET GLU PHE ASN GLN LEU TYR HIS TRP HIS SEQRES 29 B 576 PRO LEU MET PRO ASP SER PHE ARG VAL GLY PRO GLN ASP SEQRES 30 B 576 TYR SER TYR GLU GLN PHE LEU PHE ASN THR SER MET LEU SEQRES 31 B 576 VAL ASP TYR GLY VAL GLU ALA LEU VAL ASP ALA PHE SER SEQRES 32 B 576 ARG GLN PRO ALA GLY ARG ILE GLY GLY GLY ARG ASN ILE SEQRES 33 B 576 ASP HIS HIS ILE LEU HIS VAL ALA VAL ASP VAL ILE LYS SEQRES 34 B 576 GLU SER ARG VAL LEU ARG LEU GLN PRO PHE ASN GLU TYR SEQRES 35 B 576 ARG LYS ARG PHE GLY MET LYS PRO TYR THR SER PHE GLN SEQRES 36 B 576 GLU LEU THR GLY GLU LYS GLU MET ALA ALA GLU LEU GLU SEQRES 37 B 576 GLU LEU TYR GLY ASP ILE ASP ALA LEU GLU PHE TYR PRO SEQRES 38 B 576 GLY LEU LEU LEU GLU LYS CYS HIS PRO ASN SER ILE PHE SEQRES 39 B 576 GLY GLU SER MET ILE GLU MET GLY ALA PRO PHE SER LEU SEQRES 40 B 576 LYS GLY LEU LEU GLY ASN PRO ILE CYS SER PRO GLU TYR SEQRES 41 B 576 TRP LYS ALA SER THR PHE GLY GLY GLU VAL GLY PHE ASN SEQRES 42 B 576 LEU VAL LYS THR ALA THR LEU LYS LYS LEU VAL CYS LEU SEQRES 43 B 576 ASN THR LYS THR CYS PRO TYR VAL SER PHE HIS VAL PRO SEQRES 44 B 576 ASP PRO ARG GLN GLU ASP ARG PRO GLY VAL GLU ARG PRO SEQRES 45 B 576 PRO THR GLU LEU
MODRES 1PGG ASN A 68 ASN GLYCOSYLATION SITE MODRES 1PGG ASN A 144 ASN GLYCOSYLATION SITE MODRES 1PGG ASN A 410 ASN GLYCOSYLATION SITE MODRES 1PGG ASN B 68 ASN GLYCOSYLATION SITE MODRES 1PGG ASN B 144 ASN GLYCOSYLATION SITE MODRES 1PGG ASN B 410 ASN GLYCOSYLATION SITE
HET NAG A 661 14 HET NAG A 671 14 HET NAG A 672 14 HET NAG A 681 14 HET NAG B 661 14 HET NAG B 671 14 HET NAG B 672 14 HET NAG B 681 14 HET HEM A 601 43 HET IMM A 1 25 HET HEM B 601 43 HET IMM B 1 25
HETNAM NAG N-ACETYL-D-GLUCOSAMINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM IMM 1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC HETNAM 2 IMM ACID
HETSYN HEM HEME
FORMUL 3 NAG 8(C8 H15 N O6) FORMUL 9 HEM 2(C34 H32 FE N4 O4) FORMUL 10 IMM 2(C19 H16 I N O4)
HELIX 1 1 PRO A 35 TYR A 38 5 4 HELIX 2 2 ILE A 74 LEU A 82 1 9 HELIX 3 3 PRO A 86 THR A 94 1 9 HELIX 4 4 ARG A 97 ALA A 105 1 9 HELIX 5 5 ILE A 108 LEU A 123 1 16 HELIX 6 6 TRP A 139 SER A 143 1 5 HELIX 7 7 ALA A 174 PHE A 181 1 8 HELIX 8 8 LEU A 196 GLN A 208 1 13 HELIX 9 9 GLY A 231 TYR A 234 1 4 HELIX 10 10 LEU A 238 LEU A 244 1 7 HELIX 11 11 PRO A 281 SER A 283 5 3 HELIX 12 12 GLU A 290 GLY A 293 5 4 HELIX 13 13 PRO A 296 GLU A 319 1 24 HELIX 14 14 ASP A 325 GLU A 346 1 22 HELIX 15 15 TYR A 348 SER A 353 1 6 HELIX 16 16 PRO A 363 LEU A 366 5 4 HELIX 17 17 MET A 379 TYR A 385 1 7 HELIX 18 18 HIS A 388 LEU A 390 5 3 HELIX 19 19 TYR A 404 PHE A 407 1 4 HELIX 20 20 MET A 413 TYR A 417 1 5 HELIX 21 21 VAL A 419 ARG A 428 1 10 HELIX 22 22 HIS A 442 VAL A 457 5 16 HELIX 23 23 PHE A 463 ARG A 469 1 7 HELIX 24 24 PHE A 478 LEU A 481 1 4 HELIX 25 25 GLU A 486 TYR A 495 1 10 HELIX 26 26 ILE A 498 ALA A 500 5 3 HELIX 27 27 PHE A 503 LEU A 509 1 7 HELIX 28 28 GLU A 520 LEU A 535 1 16 HELIX 29 29 PRO A 538 CYS A 540 5 3 HELIX 30 30 ALA A 547 PHE A 550 5 4 HELIX 31 31 GLU A 553 THR A 561 1 9 HELIX 32 32 LEU A 564 CYS A 569 1 6 HELIX 33 33 PRO B 35 TYR B 38 5 4 HELIX 34 34 ILE B 74 LEU B 82 1 9 HELIX 35 35 PRO B 86 THR B 94 1 9 HELIX 36 36 ARG B 97 ALA B 105 1 9 HELIX 37 37 ILE B 108 LEU B 123 1 16 HELIX 38 38 TRP B 139 SER B 143 1 5 HELIX 39 39 ALA B 174 PHE B 181 1 8 HELIX 40 40 LEU B 196 GLN B 208 1 13 HELIX 41 41 GLY B 231 TYR B 234 1 4 HELIX 42 42 LEU B 238 LEU B 244 1 7 HELIX 43 43 PRO B 281 SER B 283 5 3 HELIX 44 44 GLU B 290 GLY B 293 5 4 HELIX 45 45 PRO B 296 GLU B 319 1 24 HELIX 46 46 ASP B 325 GLU B 346 1 22 HELIX 47 47 TYR B 348 SER B 353 1 6 HELIX 48 48 PRO B 363 LEU B 366 5 4 HELIX 49 49 MET B 379 TYR B 385 1 7 HELIX 50 50 HIS B 388 LEU B 390 5 3 HELIX 51 51 TYR B 404 PHE B 407 1 4 HELIX 52 52 MET B 413 TYR B 417 1 5 HELIX 53 53 VAL B 419 ARG B 428 1 10 HELIX 54 54 HIS B 442 VAL B 457 5 16 HELIX 55 55 PHE B 463 ARG B 469 1 7 HELIX 56 56 PHE B 478 LEU B 481 1 4 HELIX 57 57 GLU B 486 TYR B 495 1 10 HELIX 58 58 ILE B 498 ALA B 500 5 3 HELIX 59 59 PHE B 503 LEU B 509 1 7 HELIX 60 60 GLU B 520 LEU B 535 1 16 HELIX 61 61 PRO B 538 CYS B 540 5 3 HELIX 62 62 ALA B 547 PHE B 550 5 4 HELIX 63 63 GLU B 553 THR B 561 1 9 HELIX 64 64 LEU B 564 CYS B 569 1 6
SHEET 1 A 2 ILE A 46 PHE A 50 0 SHEET 2 A 2 ARG A 54 ASP A 58 -1 N ASP A 58 O ILE A 46 SHEET 1 B 2 TYR A 254 LEU A 257 0 SHEET 2 B 2 GLU A 260 PRO A 263 -1 N TYR A 262 O GLN A 255 SHEET 1 C 2 PHE A 395 VAL A 397 0 SHEET 2 C 2 GLN A 400 TYR A 402 -1 N TYR A 402 O PHE A 395 SHEET 1 D 2 ILE B 46 PHE B 50 0 SHEET 2 D 2 ARG B 54 ASP B 58 -1 N ASP B 58 O ILE B 46 SHEET 1 E 2 TYR B 254 LEU B 257 0 SHEET 2 E 2 GLU B 260 PRO B 263 -1 N TYR B 262 O GLN B 255 SHEET 1 F 2 PHE B 395 VAL B 397 0 SHEET 2 F 2 GLN B 400 TYR B 402 -1 N TYR B 402 O PHE B 395
SSBOND 1 CYS A 36 CYS A 47 1555 1555 2.03 SSBOND 2 CYS A 37 CYS A 159 1555 1555 2.03 SSBOND 3 CYS A 41 CYS A 57 1555 1555 2.01 SSBOND 4 CYS A 59 CYS A 69 1555 1555 2.03 SSBOND 5 CYS A 569 CYS A 575 1555 1555 2.02 SSBOND 6 CYS B 36 CYS B 47 1555 1555 2.03 SSBOND 7 CYS B 37 CYS B 159 1555 1555 2.03 SSBOND 8 CYS B 41 CYS B 57 1555 1555 2.01 SSBOND 9 CYS B 59 CYS B 69 1555 1555 2.03 SSBOND 10 CYS B 569 CYS B 575 1555 1555 2.02
LINK FE HEM A 601 NE2 HIS A 388 1555 1555 2.11 LINK C1 NAG A 661 ND2 ASN A 68 1555 1555 1.44 LINK C1 NAG A 671 ND2 ASN A 144 1555 1555 1.44 LINK O4 NAG A 671 C1 NAG A 672 1555 1555 1.38 LINK C1 NAG A 681 ND2 ASN A 410 1555 1555 1.46 LINK FE HEM B 601 NE2 HIS B 388 1555 1555 2.11 LINK C1 NAG B 661 ND2 ASN B 68 1555 1555 1.43 LINK C1 NAG B 671 ND2 ASN B 144 1555 1555 1.44 LINK O4 NAG B 671 C1 NAG B 672 1555 1555 1.38 LINK C1 NAG B 681 ND2 ASN B 410 1555 1555 1.46
CISPEP 1 SER A 126 PRO A 127 0 -0.77 CISPEP 2 SER B 126 PRO B 127 0 -0.83
SITE 1 COX 4 ARG A 120 SER A 530 TYR A 385 GLU A 524 SITE 1 PER 4 GLN A 203 HIS A 207 HIS A 388 HEM A 601 SITE 1 COB 4 ARG B 120 SER B 530 TYR B 385 GLU B 524 SITE 1 PEB 4 GLN B 203 HIS B 207 HIS B 388 HEM B 601 SITE 1 AC1 2 TYR A 55 ASN A 68 SITE 1 AC2 4 GLU A 140 ASN A 144 TYR A 147 NAG A 672 SITE 1 AC3 4 MET A 216 NAG A 671 LEU B 238 GLU B 239 SITE 1 AC4 10 TYR A 402 GLN A 406 ASN A 410 MET A 413 SITE 2 AC4 10 ASP A 416 TYR A 417 GLY B 278 ILE B 279 SITE 3 AC4 10 PRO B 280 GLN B 282 SITE 1 AC5 2 TYR B 55 ASN B 68 SITE 1 AC6 4 GLU B 140 ASN B 144 TYR B 147 NAG B 672 SITE 1 AC7 4 LEU A 238 GLU A 239 MET B 216 NAG B 671 SITE 1 AC8 8 PRO A 280 GLN A 282 TYR B 402 GLN B 406 SITE 2 AC8 8 ASN B 410 MET B 413 ASP B 416 TYR B 417 SITE 1 AC9 14 ALA A 202 GLN A 203 THR A 206 HIS A 207 SITE 2 AC9 14 PHE A 210 LYS A 211 THR A 212 LEU A 295 SITE 3 AC9 14 ASN A 382 HIS A 386 HIS A 388 MET A 391 SITE 4 AC9 14 VAL A 447 ASP A 450 SITE 1 BC1 14 MET A 113 VAL A 116 ARG A 120 VAL A 349 SITE 2 BC1 14 LEU A 352 TYR A 355 LEU A 359 LEU A 384 SITE 3 BC1 14 TRP A 387 PHE A 518 GLY A 526 ALA A 527 SITE 4 BC1 14 SER A 530 LEU A 531 SITE 1 BC2 14 ALA B 202 GLN B 203 THR B 206 HIS B 207 SITE 2 BC2 14 PHE B 210 LYS B 211 THR B 212 LEU B 295 SITE 3 BC2 14 ASN B 382 HIS B 386 HIS B 388 MET B 391 SITE 4 BC2 14 VAL B 447 ASP B 450 SITE 1 BC3 14 MET B 113 VAL B 116 ARG B 120 VAL B 349 SITE 2 BC3 14 LEU B 352 TYR B 355 LEU B 359 LEU B 384 SITE 3 BC3 14 TRP B 387 PHE B 518 GLY B 526 ALA B 527 SITE 4 BC3 14 SER B 530 LEU B 531
CRYST1 99.220 208.990 232.430 90.00 90.00 90.00 I 2 2 2 16
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.010079 0.000000 0.000000 0.00000
SCALE2 0.000000 0.004785 0.000000 0.00000
SCALE3 0.000000 0.000000 0.004302 0.00000
MTRIX1 1 -0.995539 -0.058457 0.074057 82.14900 1
MTRIX2 1 -0.058971 -0.227185 -0.972064 233.85699 1
MTRIX3 1 0.073648 -0.972095 0.222725 180.98900 1